Company Description:
Building Products & Materials Firm
Building Products & Materials Firm
Construction Executive Online
Construction Job Openings
Company News
- Effectiveness of nirsevimab in reducing hospitalizations in emergency departments due to bronchiolitis among infants under 3 months: a retrospective study | Request PDF - ResearchGate (news.google.com)
- Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York - Business Wire (news.google.com)
- Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology - Wiley Online Library (news.google.com)
- Immunoglobulin A Antibodies: From Protection to Harmful Roles - Gleeson - 2024 - Immunological Reviews - Wiley Online Library (news.google.com)
- Study: Resistance to antibody rare in RSV breakthrough cases - CIDRAP (news.google.com)
- Resistance mutations to nirsevimab are rare in respiratory syncytial virus (RSV) - Institut Pasteur (news.google.com)
- Landscape of Subcutaneous Administration Strategies for Monoclonal Antibodies in Oncology - Wiley Online Library (news.google.com)
- Nirsevimab and Hospitalization for RSV Bronchiolitis - The New England Journal of Medicine (news.google.com)
- Sanofi pledges $1bn+ to expand production facilities in France - BioProcess International (news.google.com)
- Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cells - Frontiers (news.google.com)
- COVID-19: which monoclonal antibodies should be used for vulnerable individuals? - Institut Pasteur (news.google.com)
- AbbVie Puts Potential $713M on the Line for OSE’s Inflammation Antibody - BioSpace (news.google.com)
- Antibody and antibody fragments site-specific conjugation using new Q-tag substrate of bacterial transglutaminase - Nature (news.google.com)
- Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants - The New England Journal of Medicine (news.google.com)
- Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure - The Lancet Infectious Diseases - The Lancet (news.google.com)
- Eli Lilly expands ADC scope with Mablink Bioscience acquisition - Pharmaceutical Technology (news.google.com)
- BECOME - Biospheres as Effective Conservation Measures - Universitetet i Bergen (news.google.com)
- HIV-AIDS: broadly neutralizing antibodies, stars of the lab - Institut Pasteur (news.google.com)
- Remission from HIV-1 infection: discovery of broadly neutralizing antibodies that contribute to virus control - Institut Pasteur (news.google.com)
- Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa - BMC Medicine (news.google.com)
- Man and the Biosphere Programme (MAB) - UNESCO (news.google.com)
- MilliporeSigma opens €50m France antibody production plant - BioProcess International (news.google.com)
- COVID-19: Identification of broadly SARS-CoV-2 neutralizing monoclonal antibodies - Institut Pasteur (news.google.com)
- Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies - Nature (news.google.com)
- The anti-FcεRI antibody MAR-1 depletes basophils and cross-reacts with myeloid cells through its Fc portion - Wiley Online Library (news.google.com)
- Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells - Nature (news.google.com)
- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization - Nature (news.google.com)
- Early Emergence of Adaptive Mechanisms Sustaining Ig Production: Application to Antibody Therapy - Frontiers (news.google.com)
- Technical guidelines for biosphere reserves - UNESCO (news.google.com)
- Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing - Nature (news.google.com)
- High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2 - Wiley Online Library (news.google.com)
- On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency - Nature (news.google.com)
- Pierre Fabre offloading MAb plant as it moves away from contract manufacturing - BioProcess International (news.google.com)
- Good Practices - en.unesco.org (news.google.com)
- OSE Immunotherapeutics Announces Artificial Intelligence Antibody Drug Development Collaboration with MAbSilico - Business Wire (news.google.com)
- World Network of Biosphere Reserves - en.unesco.org (news.google.com)
- Generation and characterization of novel anti-DR4 and anti-DR5 antibodies developed by genetic immunization - Nature (news.google.com)
- 2018 UNESSCO MAB Young Scientists Awards for Developing Countries’ Scientists ($USD 5,000 Prize) - Opportunities For Africans (news.google.com)
- What we know so far about the clinical trial disaster in France - Science | AAAS (news.google.com)
- Ovarian Cancer Kills 50,000 Every Year. Now a French Biotech has Bagged €15M to Fight it. - Labiotech.eu (news.google.com)
- Patronage Laique & Social Housing / LAPS Architecture + MAB Arquitectura - ArchDaily (news.google.com)
- 2014 UNESCO MAB Young Scientists Awards. (US$ 5,000 for Young Researchers) - Opportunities For Africans (news.google.com)
- UNESCO MAB Session Adds 12 Sites to the World Network of Biosphere Reserves - SDG Knowledge Hub (news.google.com)
- An Official Journal Of The NRA | MAB P-15 - American Rifleman (news.google.com)